In this week’s issue:
- For researchers intending to apply for the March 2015 Transitional Open Operating Grant, a reminder that the registration deadline is early – January 9, 2015.
- The Arthritis Society –Strategic Operating Grant
- CIHR Strategy for Patient-Oriented Research – Patient Engagement – Collaboration Grants
- Give to Cure – 2015 Global Alzheimer’s Challenge
- The Arthritis Society – Young Investigator Operating Grant
- Enhancing Life Project – Letters of Intent for Scholarly Projects
- Sontag Foundation – Distinguished Scientist Awards
Awards and Honours:
- McGill University – The Louis and Artur Lucian Award for Research in Circulatory Diseases
LOI Deadline: January 9, 2015; 4pm ET
The Strategic Operating Grants (SOG) program provides funding to support research proposals aligned with The Society’s priorities. Consistent with the Society’s 2015-2020 Research Strategy, Requests for Applications (RFAs) for SOG will be published for each theme (typically one theme a year). The Society will be accepting applications relevant to:
Strategic Theme I: Improving our understanding of arthritis and finding the cure Research under this theme will seek to improve our understanding of the causes of arthritis in order to develop new approaches to alleviate the pain, prevent and/or slow the progression of disease (including early diagnosis), restore joint function, and eventually cure those affected by arthritis.
For the 2015-16 grant competition season, The Society will fund up to six (6) SOG applications. In addition to the priorities outlined in the 2015-2020 Research Strategy, The Society has committed to fund at least one meritorious project on Medical Cannabis aligned with Strategic Theme I. The maximum award per application is $120,000 annually for up to three years.
Please visit The Arthritis Society website for further details.
Deadline: January 13, 2015
As a partner in SPOR, one of CIHR’s goals is to enhance citizen and patient engagement in health research. A funding strategy for patient engagement in patient-oriented research is introducing a number of complementary funding opportunities whose objective is to build capacity in CIHR’s research communities for meaningfully engaging patients, citizens and health care professionals as active partners in patient-oriented research.
The objective of this funding opportunity is to facilitate the realization of the goals of the SPOR Patient Engagement Framework for the development of active collaborations, specifically:
- Identify and implement inclusive engagement mechanisms, processes and approaches that value patient perspectives, experiences and skills throughout the research process; and
- Facilitate opportunities for researchers and knowledge users, including patients, to work together to identify problems and gaps, set priorities for research, and produce and implement solutions.
The total amount available for this funding opportunity is $150,000, enough to fund approximately ten grants. CIHR’s maximum contribution per grant is up to $15,000 for up to one year. This funding is non-renewable.
To be funded through this competition, applicants must secure, by the application deadline, new partner funds (from non-federal sources) at a minimum of 1:1 ratio to the amount requested from CIHR.
Matching partner contributions can include up to 25% eligible cash equivalent contributions. Partner contributions cannot be funds that have previously been leveraged for other CIHR initiatives.
For full details on this funding opportunity, please visit the website: https://www.researchnet-recherchenet.ca/rnr16/vwOpprtntyDtls.do?prog=2166&view=currentOpps&org=CIHR&type=EXACT&resultCount=25&sort=program&all=1&masterList=true
LOI Deadline: January 13, 2015
Give to Cure, a nonprofit organization devoted to accelerating the process of finding cures for the most pressing human diseases of our time, combines the power of the crowd with world-class leaders in scientific research, business, and government to speed the funding of clinical trials and drive promising cures to people in need.
GTC has issued a Request for Applications for the 2015 Global Alzheimer’s Challenge, a competition designed to accelerate the development of treatments for Alzheimer’s disease by directly funding the world’s most promising Alzheimer’s-related clinical trials.
To be eligible, proposed clinical trials must test biomedical (drugs, treatments, devices) interventions for Alzheimer’s disease. Repurposed treatments are acceptable, and clinical trials must be ready to enter Phase I or Phase II within three months of receipt of initial funding.
Letters of Intent must be received no later than January 13, 2015. Upon review, selected applicants will be invited to submit full applications, which will be due by March 30, 2015.
See the Give to Cure website for complete program guidelines, a brief FAQ, and application instructions.
LOI Deadline: January 14, 2015; 4pm ET
The Young Investigator Operating Grant program is intended to promote creativity in all domains of arthritis-related research and is not restricted to any one strategic theme set out in the Society’s 2015-2020 research strategy. It is open to individuals within 4 years of their first academic appointment, and have never previously held an operating grant (as PI) of more than $70,000 from the Society, CAN, CIHR, NSERC or other funding agency. The Society is aiming to fund up to 4 projects. The maximum award per application is $100,000 annually for terms up to three years. Applicants may also request a $25,000 equipment grant in the first year of the award.
Please visit The Arthritis Society website for further details.
LOI Deadline: February 1, 2015
Given the profound expansion of human power through technology as well as advances in genetics, ecology, and other fields, the vulnerability, endangerment, and enhancement of life are dominant themes in the global age. As such, the Enhancing Life Project, a collaboration between the University of Chicago and Ruhr University Bochum, aims to explore this rich but widely unexamined dimension of human aspiration and social life, and increase knowledge so that life might be enriched.
To that end, the project supports relevant scholarly research projects in the areas of religious thought, theology, and philosophy; philosophy of biology, science, and technology; social sciences; and communications and media studies. The initiative will support the research projects of fifteen advanced career scholars with awards of $100,000 each and the projects of twenty early career scholars with awards of $50,000 each.g
Letters of Intent are due no later than February 1, 2015. Upon review, selected applicants will be invited to submit full proposals, which must be returned by April 20, 2015.
To be eligible, scholars must have a doctoral degree (or equivalent) and be affiliated with an accredited college or university (or be affiliated with another major public or private research institution).
Complete program guidelines and application instructions are available on the Enhancing Life Project website.
Deadline: March 19, 2015
The Sontag Foundation was established to fund biomedical research, with a primary focus on brain cancer and provide additional support for rheumatoid arthritis. Providing grant support to programs helping individuals in Northeast Florida become more self-sufficient has also become a priority of the foundation.
To that end, the foundation is seeking nominations for its 2015 Distinguished Scientist Awards. The annual award provides $600,000 over a four-year period to early career scientists who demonstrate potential to create new thinking in the brain cancer field.
To be eligible, applicants must hold a doctoral degree in a discipline that can be brought to bear on brain cancer. At the time of application, applicants must hold their first independent full-time faculty appointment at the level of assistant professor, independent researcher, or equivalent position at a tax-exempt 501(c)(3) academic, research, or medical institution within the United States or an equivalent institution in Canada. In addition, the applicant’s initial faculty appointment must have been made no earlier than March 1, 2012.
Visit the Sontag Foundation website for complete program guidelines, information about previous winners, and application instructions.
AWARDS AND HONOURS:
Nomination Deadline: March 20, 2015
The Louis and Artur Lucian Award was established through a bequest to McGill University under the will of the late Olga Leibovici to honour the donor’s two brothers, and was conferred for the first time in 1978. The Award is designed to honour outstanding research in the field of circulatory diseases by a scientific investigator or group of investigators whose contribution to knowledge in this field is deemed worthy of special recognition. As per the terms of the bequest, the work of the nominee must be current. The Louis and Artur Lucian Award consists of a $60,000 CDN prize to the recipient. It is hoped that through this Award, collaborative research in the field of circulatory diseases can be established between McGill and research centres elsewhere in Canada, the United States and other countries of the world.
The successful recipient is invited to spend a minimum of a one- to two-week period of time at McGill University to give a formal Lucian Lecture, to have interchanges with members of the McGill community, and possibly to undertake a research collaboration with McGill investigators in the field of circulatory diseases. Prospective recipients should be nominated on the form provided. This form, together with the supporting materials, should be returned to Dr. Jacques Genest, Chair, the Louis and Artur Lucian Award Committee. The Award Committee recognizes no geographical limitations, and nominations are invited without distinction as to gender or nationality. Preference will be given to work done in the recent past.
For further information, and to download the nomination form, please visit website at http://www.mcgill.ca/lucianaward/.